METHODS	The primary end point was the proportion of patients experiencing relapse ( worse scores on the IRLS and investigator-rated Clinical Global Impression of Change scale on 2 consecutive visits at least 1 week apart or withdrawal because of lack of efficacy ) during the DB phase .\